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Meditation May Diminish The Symptoms of Postural Orthostatic Tachycardia
Syndrome (POTS)
Introduction

Various forms of meditation have been
integrated into treatment options because of
the derived benefits. Transcendental
Meditation (TM) has been shown to decrease
heartrate, blood pressure, and stress
symptoms (Seaward, 2018). Additionally,
Mindfulness Meditation (MM) has been shown
to decrease anxiety and has been used in
different treatments for chronic disorders
(Buchholz, 2015). To my knowledge, no
previous research has looked at the beneficial
effects of meditation as a treatment option for
POTS. POTS is a dysautonomic disorder
characterized by an increase in HR by greater
than 30 bpm and an intolerance of orthostatic
fluctuations. Since this significantly affects
physiological and psychological aspects of
functioning and current treatment options are
inconsistently effective, this is an important
area to investigate. I hypothesized that while
both forms will be beneficial, TM will be more
beneficial than MM. Additionally, I
hypothesized that participants with POTS
would have greater overall benefits than
healthy control participants.

Method

Study one: Five participants with POTS
completed a within subject meditation
experiment. During one session they
completed a control task and in the second
session, a TM task. Both times they
answered pretest and posttest questions
from COMPASS, Calgary, and overall
wellness scales. They also had their BP and
HR measured before and after the videos.
Study two: 40 control participants were
divided into 3 groups: control condition
(n=10), TM condition (n=11), and MM
condition (n=12). They each completed one
session where they answered pretest and
posttest questions from the Calgary,
COMPASS, and overall wellness scales.
They also had their HR and BP measured
before and after the video.

Results

Study One

Figure 1: Systolic BP responses: Line
1- TM, Line 2- Control

Figure 2: HR reponsses: Line 1TM, Line 2- Control

Figure 3: COMPASS responses: Line
1- TM, Line 2- Control

Study one: MANOVA analyses were conducted to determine if
there was a significant difference from the control session to the
TM session, as well as from the pretest to posttest of each
condition. No significance was found, but strong effect sizes
indicated measurable differences. The strongest effect size
suggested effects between control and TM conditions accounted
for 87% of the variance in systolic BP (F(1,3)= 20.694, p < .020,
ƞp² = .873). Additionally, there was a moderate effect between the
pretest and posttest for the TM group (F(1,3)= .932, p < .406, ƞp²
= .237), When examining the heart rate, there was a strong effect
size between the TM condition and the control condition (F(1,4)=
2.791, p < .170, ƞp² = .411) and a moderate effect size between
the pretest and posttest for TM (F(1,4)= .002, p < .966, ƞp² = .10).
For the Calgary scale, there was a moderate effect size of
responses for the TM condition compared to the control condition
(F(1,4)= .909, p < .394, ƞp² = .185) and a strong effect size
for the pretest and posttest of the TM condition (F(1,4)= 2.243, p
< .209, ƞp² = .359). For the COMPASS scale, there were no
significant effect sizes between the control and TM condition, but
there was a moderate difference between the pre- and posttests
of the TM condition (F(1,4)= .044, p < .845, ƞp² = .195). (Refer to
figures 1-4).
Study two: MANOVA analyses were conducted to determine if
there were significant differences between the pre- and postmeasures of each condition. Significance was found for the
Calgary responses for both TM (F(1,11)= 6.80, p < .004) and MM
(F(1,12)= 3.93, p < .oo1) conditions. There were no other
significant results from any scales in all three conditions.
Confidence Intervals where conducted to determine if there was
any significant difference in results from study one to study two,
but there was no significance found.

Discussion

Figure 4: Calgary responses:
Line 1- TM, Line - Control

There were no significant results to indicate TM has a
beneficial effect on symptoms of POTS, but the various
effect sizes suggest a larger sample size could result in
significance. Although the interactions between HR and
BP were the opposite of what I hypothesized, all of the
other interactions show a trend toward improvement as a
result of the meditation. Results from Study two showed
both Mindfulness and Transcendental Meditation had a
significant impact in reducing perceived stress symptoms,
however no significance was found to indicate the effect
on HR, BP, and overall feelings of wellness. Although I
hypothesized TM to have a more significant impact on
participants with POTS, results did not support that
hypothesis.

